Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease

ClinicalTrials.gov ID: NCT00594386

Public ClinicalTrials.gov record NCT00594386. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 12:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension to the Double-Blind SP650 Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Subjects With Advanced-Stage Idiopathic Parkinson's Disease.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this open-label extension is to assess the safety and tolerability of long-term treatment of the Rotigotine patch in subjects with advanced-stage idiopathic Parkinson's Disease.

Study identification

NCT ID
NCT00594386
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
UCB Pharma
Industry
Enrollment
258 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
31 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2002 (Type not available)
Primary completion
Dec 2008 (Actual)
Completion
Dec 2008 (Actual)
Last update posted
Oct 2, 2014

2002 – 2008

United States locations

U.S. sites
37
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
Not listed Huntsville Alabama — —
Not listed Peoria Arizona — —
Not listed Phoenix Arizona — —
Not listed Tucson Arizona — —
Not listed Hot Springs Arkansas — —
Not listed Fountain Valley California — —
Not listed Fresno California — —
Not listed Irvine California — —
Not listed Los Angeles California — —
Not listed Danbury Connecticut — —
Not listed Fairfield Connecticut — —
Not listed New Haven Connecticut — —
Not listed Miami Florida — —
Not listed Pompano Beach Florida — —
Not listed St. Petersburg Florida — —
Not listed Sunrise Florida — —
Not listed Atlanta Georgia — —
Not listed Hoffman Estates Illinois — —
Not listed Fort Wayne Indiana — —
Not listed Kansas City Kansas — —
Not listed Lexington Kentucky — —
Not listed Boston Massachusetts — —
Not listed Southfield Michigan — —
Not listed Minneapolis Minnesota — —
Not listed Henderson Nevada — —
Not listed Albany New York — —
Not listed Forest Hills New York — —
Not listed Louisville New York — —
Not listed Asheville North Carolina — —
Not listed Raleigh North Carolina — —
Not listed Toledo Ohio — —
Not listed Upland Pennsylvania — —
Not listed Houston Texas — —
Not listed San Antonio Texas — —
Not listed Richmond Virginia — —
Not listed Roanoke Virginia — —
Not listed Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00594386, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 2, 2014 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00594386 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →